India, Aug. 7 -- More than 150 deaths have been reported in connection with weight loss injections, according to figures from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). It also revealed that patients using weight loss medicines have made around 150,000 reports of possible side effects and other adverse reactions.
The data were collected from the MHRA's Yellow Card scheme, which allows patients, relatives and medics to report side effects of medication.
Notably, the reports cover GLP-1 medicines available through the NHS, including liraglutide, sold as Saxenda; semaglutide, sold as Wegovy; and tirzepatide, sold as Mounjaro.
The findings showed 106,189 adverse reaction reports and 120 deaths suspected of being lin...